Kamran Alam
2018 - Aquinox Pharmaceuticals
In 2018, Kamran Alam earned a total compensation of $1.8M as Interim Chief Financial Officer and Vice President, Finance at Aquinox Pharmaceuticals, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $127,750 |
|---|---|
| Option Awards | $1,262,777 |
| Salary | $365,000 |
| Total | $1,755,527 |
Alam received $1.3M in option awards, accounting for 72% of the total pay in 2018.
Alam also received $127.8K in non-equity incentive plan and $365K in salary.
Rankings
In 2018, Kamran Alam's compensation ranked 6,377th out of 14,244 executives tracked by ExecPay. In other words, Alam earned more than 55.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,377 out of 14,244 | 55th |
Division Manufacturing | 2,437 out of 5,765 | 58th |
Major group Chemicals And Allied Products | 907 out of 2,128 | 57th |
Industry group Drugs | 762 out of 1,817 | 58th |
Industry Pharmaceutical Preparations | 591 out of 1,391 | 58th |
Source: SEC filing on October 2, 2019.
Alam's colleagues
We found two more compensation records of executives who worked with Kamran Alam at Aquinox Pharmaceuticals in 2018.
News
Taysha Gene Therapies CEO Sean Nolan's 2023 pay slips 20% to $1.5M
April 18, 2024
Taysha Gene Therapies CEO RA Session's 2022 pay falls 57% to $2M
May 8, 2023
Taysha Gene Therapies CEO RA Session's 2021 pay slips 3% to $4.6M
April 28, 2022
Inotek Pharmaceuticals CEO Gaurav Shah's 2019 pay falls 39% to $3.9M
April 24, 2020
Aquinox Pharmaceuticals CEO Jonathan Drachman receives $3.8M in 2019
March 24, 2020
Aquinox Pharmaceuticals CEO David Main's 2018 pay jumps 39% to $4.2M
October 2, 2019